Related Experiment Video
Updated: Aug 4, 2026

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
Published on: June 29, 2011
Sustained activation of p34(cdc2) is required for noscapine-induced apoptosis
K Ye1, J Zhou, J W Landen
1Department of Cell Biology, Emory University School of Medicine, 1648 Pierce Dr., Atlanta, GA 30322, USA.
Abstract:
Mitotic arrest and subsequent apoptosis has been observed in many types of cells treated with anti-microtubule agents. However, the molecular mechanisms underlying the two events as well as their relationship are not well understood; on the contrary, there has been increasing evidence indicating that anti-microtubule agents might induce apoptosis via signaling pathways independent of mitosis. In this study, we found that apoptosis induced by noscapine, an anti-microtubule drug previously shown to cause both mitotic arrest and apoptotic cell death, was blocked by inhibiting p34(cdc2) activity with olomoucine in FM3A murine mammary carcinoma cells or by reducing the level and activity of p34(cdc2) in a mutant cell line FT210 derived from FM3A. Furthermore, transfection of the mutant FT210 cells with wild-type p34(cdc2) restored their ability to undergo mitotic arrest and then apoptosis in response to noscapine. Thus, we conclude that sustained activation of the p34(cdc2) kinase during mitotic arrest is required for subsequent apoptosis induced by noscapine, establishing a link between the two events.
Insights
Noscapine, an anti-microtubule drug, triggers cell death. This study reveals that sustained p34(cdc2) kinase activation during mitotic arrest is crucial for noscapine-induced apoptosis, linking these two cellular events.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Anti-microtubule agents cause mitotic arrest and apoptosis.
- The relationship and molecular mechanisms linking these events are not fully understood.
- Evidence suggests anti-microtubule agents may induce apoptosis through mitosis-independent pathways.
Purpose of the Study:
- To investigate the role of p34(cdc2) kinase in noscapine-induced apoptosis.
- To establish a link between mitotic arrest and apoptosis mediated by anti-microtubule drugs.
- To elucidate the molecular mechanisms underlying noscapine's effects on cell death.
Main Methods:
- Utilized FM3A murine mammary carcinoma cells and a p34(cdc2) deficient mutant cell line (FT210).
- Inhibited p34(cdc2) activity using olomoucine.
- Restored p34(cdc2) function in mutant cells via transfection with wild-type p34(cdc2).
Main Results:
- Apoptosis induced by noscapine was blocked by inhibiting p34(cdc2) activity with olomoucine.
- Reducing p34(cdc2) level and activity in FT210 cells also blocked noscapine-induced apoptosis.
- Restoring wild-type p34(cdc2) in FT210 cells re-established sensitivity to noscapine-induced mitotic arrest and apoptosis.
Conclusions:
- Sustained activation of p34(cdc2) kinase during mitotic arrest is essential for noscapine-induced apoptosis.
- This study establishes a direct link between mitotic arrest and apoptosis mediated by noscapine.
- p34(cdc2) activation is a critical molecular event connecting anti-microtubule drug-induced mitotic arrest to subsequent cell death.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Anaphase Promoting Complex
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
DNA Damage Can Stall the Cell Cycle

